You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 131 No. 11, November 1996 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (6)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Glucocorticoid Receptor Antagonism by Mifepristone Alters Phosphocreatine Breakdown During Sepsis

Tadashi Mitsuo, MD; Jan Rounds; Derek Prechek, MS; Douglas W. Wilmore, MD; Danny O. Jacobs, MD

Arch Surg. 1996;131(11):1179-1185.


Abstract

Objective
To determine the role of glucocorticoids in the regulation of myocellular energetics induced by sepsis by means of the glucocorticoid receptor antagonist mifepristone (RU 38486).

Design
Randomized controlled study.

Setting
University laboratories.

Participants
Thirty-two adult male Wistar rats.

Methods
Animals were randomly assigned to 1 of 4 groups. In 2 groups, mifepristone (10 mg/kg) was administered by gavage feeding 2 hours before cecal ligation and single 18-gauge needle puncture or sham operation. The other 2 groups of animals received placebo gavage feedings 2 hours before their surgical procedures. Twenty-four hours after operation, high-energy phosphate ratios, intracellular pH, the forward rate constant for the creatine kinase reaction, and phosphocreatine breakdown rates were measured in the gastrocnemius muscle by in vivo phosphorus 31 magnetic resonance spectroscopy. Tissue and blood samples were collected to measure creatine and adenosine 5'-triphosphate concentrations, Na+-K+ adenosine triphosphatase activity, and circulating corticosterone levels.

Results
Circulating corticosterone levels were twice as high in septic animals as in sham-operation control rats (P<.01). Phosphocreatine breakdown rates and Na+-K+ adenosine triphosphatase activity were significantly higher (40% and 75%, respectively; P<.01) in placebo-treated septic rats than in sham-operation control rats. However, phosphocreatine breakdown rates and Na+-K+ adenosine triphosphatase activity in mifepristone-treated septic animals were not significantly elevated above control levels.

Conclusion
Pretreatment with mifepristone reduces the demand for adenosine triphosphate production from phosphocreatine breakdown and downregulates Na+-K+ adenosine triphosphatase activity during sepsis.

Arch Surg. 1996;131:1179-1185



Author Affiliations

From the Laboratory for Surgical Metabolism and Nutrition and NMR Laboratory for Physiological Chemistry, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Sepsis Increases the Plasma Membrane Content of {alpha}1 and {alpha}2 Isoforms of Na+-K+ Adenosine Triphosphatase in Rat Skeletal Muscle
Shimoda et al.
Arch Surg 2001;136:95-100.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.